loading

Eyepoint Pharmaceuticals Inc Borsa (EYPT) Ultime notizie

pulisher
07:45 AM

How EyePoint Pharmaceuticals Inc. stock performs in high volatility marketsWall Street Watch & Fast Gaining Stock Strategy Reports - newser.com

07:45 AM
pulisher
07:04 AM

EyePoint Announces Participation at Upcoming Investor Conferences - EyePoint Pharmaceuticals

07:04 AM
pulisher
07:00 AM

EyePoint (NASDAQ: EYPT) to appear at Guggenheim, Stifel and Jefferies investor events - Stock Titan

07:00 AM
pulisher
03:08 AM

Should you wait for a breakout in EyePoint Pharmaceuticals Inc.Market Sentiment Summary & Daily Profit Focused Screening - newser.com

03:08 AM
pulisher
02:56 AM

Is EyePoint Pharmaceuticals Inc. stock ready for breakoutQuarterly Risk Review & Weekly Stock Breakout Alerts - newser.com

02:56 AM
pulisher
01:30 AM

What’s next for EyePoint Pharmaceuticals Inc. stock priceTrade Volume Summary & Fast Entry High Yield Tips - newser.com

01:30 AM
pulisher
Nov 02, 2025

EyePoint Pharmaceuticals Inc. stock outlook for YEAROptions Play & Precise Trade Entry Recommendations - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will EyePoint Pharmaceuticals Inc. (PV3B) stock deliver compounding returnsPortfolio Performance Summary & Long-Term Capital Growth Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Has EyePoint Pharmaceuticals Inc. formed a bullish divergenceJobs Report & Growth Oriented Trading Recommendations - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Will EyePoint Pharmaceuticals Inc. stock split attract more investorsBond Market & AI Powered Market Trend Analysis - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Is EyePoint Pharmaceuticals Inc. (PV3B) stock a buy before new product rollout - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Combining price and volume data for EyePoint Pharmaceuticals Inc.July 2025 Institutional & Fast Gain Stock Trading Tips - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

EyePoint Pharmaceuticals (NASDAQ:EYPT) shareholder returns have been stellar, earning 212% in 5 years - simplywall.st

Oct 31, 2025
pulisher
Oct 31, 2025

Eyepoint Pharmaceuticals (EYPT) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2025
pulisher
Oct 30, 2025

EyePoint Pharmaceuticals Inc Stock Analysis and ForecastCandlestick Pattern Analysis & Consistently Superior Profits - earlytimes.in

Oct 30, 2025
pulisher
Oct 30, 2025

With 57% institutional ownership, EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) is a favorite amongst the big guns - Yahoo Finance

Oct 30, 2025
pulisher
Oct 30, 2025

Will EyePoint Pharmaceuticals Inc. stock outperform growth indexesTrade Risk Report & Free High Return Stock Watch Alerts - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

EyePoint Pharmaceuticals to Host Conference Call for Q3 2025 Financial Results on November 5, 2025 - Quiver Quantitative

Oct 29, 2025
pulisher
Oct 29, 2025

EyePoint to Report Third Quarter 2025 Financial Results on November 5, 2025 - The Manila Times

Oct 29, 2025
pulisher
Oct 29, 2025

EyePoint Pharmaceuticals (NASDAQ: EYPT) sets 8:30 a.m. ET call to discuss Q3 results - Stock Titan

Oct 29, 2025
pulisher
Oct 28, 2025

Will EyePoint Pharmaceuticals Inc. stock see insider buyingJuly 2025 Momentum & Weekly High Momentum Picks - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 28, 2025

Is EyePoint Pharmaceuticals Inc. stock recession proof2025 Risk Factors & Verified Short-Term Trading Plans - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 27, 2025

Is EyePoint Pharmaceuticals Inc. stock a safe buy before earningsWeekly Stock Recap & Smart Money Movement Tracker - fcp.pa.gov.br

Oct 27, 2025
pulisher
Oct 27, 2025

EyePoint Pharmaceuticals Completes US$150 Million Follow-On Equity Offering - Global Legal Chronicle

Oct 27, 2025
pulisher
Oct 27, 2025

What drives EyePoint Pharmaceuticals Inc stock priceDouble Top/Bottom Patterns & Maximize Gains Professionally - earlytimes.in

Oct 27, 2025
$37.33
price down icon 0.21%
$92.90
price down icon 0.29%
$28.82
price up icon 0.74%
$104.39
price up icon 0.46%
biotechnology ONC
$312.52
price up icon 0.95%
$182.24
price down icon 3.63%
Capitalizzazione:     |  Volume (24 ore):